Also known as A-5 retina peptide · retinal peptide complex
A natural retina peptide complex (Cytomax A-5) from the Khavinson bioregulator line, marketed for eye and retinal support.
Research refreshed
Visoluten is a natural peptide complex extracted from retinal tissue (peptide complex A-5), part of the Russian Cytomax / Revilab bioregulator line. It is marketed within the Khavinson tradition for eye and retinal support, with no defined synthetic short-peptide counterpart in the catalog.
Visoluten is the retina-directed natural bioregulator of the Cytomax / Revilab line, extracted from retinal tissue. It has no defined synthetic Cytogen counterpart in this catalog — the extract is the only form marketed within the tradition.
As a tissue extract it is a standardized polypeptide fraction with no single molecular formula or sequence. Its retinal claims come from the same concentrated research tradition as the rest of the series, with limited independent replication, and it is not FDA-approved.
Proposed tissue-selective (bioregulator) modulation of retinal-cell gene expression, in the Cytomax extract tradition.
Behind every vial of Visoluten is the same exacting pipeline every research peptide runs — but the chemistry plays out differently for this molecule. Here is how Visoluten, specifically, is brought into being.
Visoluten begins not as a powder but as a specification. Before a single bond is made, the target sequence, salt form, and purity threshold are written down as the contract the finished material must meet.
Visoluten is assembled by solid-phase peptide synthesis — the chain grows one protected residue at a time on resin, and what you fail to build cleanly here you pay to remove later.
The crude mixture — Visoluten plus its deletions and side products — is then separated on preparative HPLC, and where the cut is taken decides the difference between a genuinely pure peptide and a barely-passable one.
A real batch of Visoluten proves itself: identity confirmed by mass spectrometry, purity read directly off an analytical HPLC trace, water and counterion content measured. That batch-specific certificate of analysis is the only honest way to know what is actually in a vial of Visoluten — and a short, cold, accountable chain of custody is how that purity survives the trip to your bench.
Visoluten is a natural retina peptide extract (complex A-5), a fractionated polypeptide preparation rather than a synthesized peptide. Consistency and characterization of the fraction are the quality challenge.
Don't judge a vial by its cake. A fluffy, good-looking lyophilized powder reflects bulking agents and freeze-drying parameters — not purity. Insist on a batch-specific certificate of analysis.
Visoluten is a natural retina peptide complex (Cytomax A-5), marketed for eye and retinal support within the Khavinson bioregulator tradition.
No — Visoluten has no defined synthetic Cytogen peptide in this catalog; the tissue extract is the only marketed form.
No — it is a tissue extract (a polypeptide fraction), so it has no single sequence or molecular formula.
No — it is a research compound / supplement, not FDA-approved. This page is a research and educational reference.
The active fragment of parathyroid hormone — a recombinant peptide that builds bone, exploiting a paradox: the same hormone resorbs bone when continuous, but builds it when pulsed.
ViewRecombinant 191-amino-acid human growth hormone — a folded protein biologic identical in sequence to pituitary GH, not a synthetic research peptide.
ViewThe downstream effector of growth hormone — a 70-amino-acid recombinant protein, structurally a cousin of proinsulin, that carries out most of GH’s growth signal.
ViewDosing protocols, mechanism, comparisons, and the latest trials — citation-backed answers grounded in PubMed, PubChem, and ClinicalTrials.gov.